What does it take to fight a pandemic? Proactive measures around the world–and swift action from big pharma. Pfizer came first with its life-saving vaccine for COVID-19. At an unprecedented pace, the vaccine was developed, studied and approved for public use. All in less than a year’s time.
In this fireside chat with Barbara Sosnowski, PhD, Vice President and Global Head Emerging Science & Innovation Lead of Pfizer, will share what Pfizer learned from the COVID-19 pandemic. We’ll get an inside view on Pfizer’s big year: the challenges, triumphs and lessons for the future, and how COVID-19 changed big pharma. In this special session moderated by Leslie Loveless, CEO and Partner of Slone Partners, we’ll explore what that means for the pharmaceutical industry at large.
